Table 4.
Group | n | NO (µM) | AST(GOT) (unit/L) | ALT(GPT) (unit/L) | C-RP (ng/mL) |
---|---|---|---|---|---|
N | 12 | 23.8 ± 1.6 c | 27.1 ± 2.4 c | 31.3 ± 2.1 a | 167.0 ± 18.1 b |
S | 12 | 39.3 ± 5.1 a | 48.9 ± 3.8 a | 46.6 ± 2.5 b | 227.0 ± 20.0 a |
L | 12 | 33.5 ± 2.7 b | 43.1 ± 2.3 b | 40.2 ± 3.0 c | 211.5 ± 10.4 a |
M | 12 | 25.7 ± 1.6 b | 40.5 ± 2.6 b | 36.3 ± 2.1 d | 220.9 ± 19.9 a |
H | 12 | 24.7 ± 1.5 c | 25.0 ± 2.3 c | 27.4 ± 2.3 a | 181.4 ± 16.7 b |
P | 12 | 25.0 ± 3.5 c | 16.6 ± 3.1 d | 19.6 ± 2.4 e | 188.5 ± 17.9 b |
Values not sharing letters in the same vertical column differ significantly from one another by one-way ANOVA and Duncan’s Multiple Range Test (p < 0.05) among six groups. N: Normal group, S: Sepsis group (i.p. LPS), L: Sepsis group with low-dose WBG, M: Sepsis group with moderate-dose WBG, H: Sepsis group with high-dose WBG, P: Positive control group (i.p. PDTC).